Tokyo Tape
Sign in
← AuBEX

Quarterly report · Q3

3583.TEDINET S100SSAY
Period2023-04-01 → 2023-12-31
Filed2024-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥3.9bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥5.3bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥4.0bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥400m2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥507m2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥418m2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥639m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥519m2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥417m2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥561m2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥297m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥469m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥365m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥297m2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥365m2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥9.4bnat 2023-12-31Cons.Assets
Total assets¥9.3bnat 2023-03-31Cons.Assets
Total assets¥9.5bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥3.3bnat 2023-12-31Cons.Liabilities
Total liabilities¥3.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥6.1bnat 2023-12-31Cons.Net assets
Net assets / equity¥5.8bnat 2023-03-31Cons.Net assets
Net assets / equity¥5.7bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥2.7bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥2.5bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥106.792023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.592023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥169.172022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥131.722022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥34.342022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio64.6%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio60.3%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue2023-04-01 → 2023-12-31¥1.2bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.2bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥861,000
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentsegment profit2023-04-01 → 2023-12-31¥103m
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue2023-04-01 → 2023-12-31¥2.8bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue external2023-04-01 → 2023-12-31¥2.8bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentsegment profit2023-04-01 → 2023-12-31¥535m
—segment totalrevenue2023-04-01 → 2023-12-31¥3.9bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥3.9bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥861,000
—segment totalsegment profit2023-04-01 → 2023-12-31¥638m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥861,000
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥638m
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥3m
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥73m
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥644m
—segment totalrevenue2022-04-01 → 2022-12-31¥4.0bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥4.0bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥3m
—segment totalsegment profit2022-04-01 → 2022-12-31¥717m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥4.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥4.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥3m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥717m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 369
ItemContextValueUnit
Other nclPrior1YearInstant515000JPY
Other nclCurrentQuarterInstant515000JPY
Noncurrent liabilitiesPrior1YearInstant2111068000JPY
Noncurrent liabilitiesCurrentQuarterInstant1783764000JPY
LiabilitiesPrior1YearInstant3494583000JPY
LiabilitiesCurrentQuarterInstant3328723000JPY
Capital stockPrior1YearInstant1939834000JPY
Capital stockCurrentQuarterInstant1939834000JPY
Capital surplusPrior1YearInstant518489000JPY
Capital surplusCurrentQuarterInstant518489000JPY
Retained earningsPrior1YearInstant3435330000JPY
Retained earningsCurrentQuarterInstant3670908000JPY
Treasury stockPrior1YearInstant-206244000JPY
Treasury stockCurrentQuarterInstant-201060000JPY
Shareholders equityPrior1YearInstant5687410000JPY
Shareholders equityCurrentQuarterInstant5928172000JPY
Valuation difference on available for sale securitiesPrior1YearInstant51913000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant52042000JPY
Revaluation reserve for landPrior1YearInstant27151000JPY
Revaluation reserve for landCurrentQuarterInstant27151000JPY
Foreign currency translation adjustmentPrior1YearInstant66955000JPY
Foreign currency translation adjustmentCurrentQuarterInstant77829000JPY
Valuation and translation adjustmentsPrior1YearInstant146020000JPY
Valuation and translation adjustmentsCurrentQuarterInstant157023000JPY
Net assetsPrior1YearInstant5833431000JPY
Net assetsCurrentQuarterInstant6085196000JPY
Liabilities and net assetsPrior1YearInstant9328014000JPY
Liabilities and net assetsCurrentQuarterInstant9413919000JPY
Net salesPrior1YTDDuration3965370000JPY
Net salesCurrentYTDDuration3929420000JPY
Cost of salesPrior1YTDDuration2516564000JPY
Cost of salesCurrentYTDDuration2566434000JPY
Gross profitPrior1YTDDuration1448805000JPY
Gross profitCurrentYTDDuration1362985000JPY
Selling general and administrative expensesPrior1YTDDuration942258000JPY
Selling general and administrative expensesCurrentYTDDuration962662000JPY
Operating incomePrior1YTDDuration506546000JPY
Operating incomeCurrentYTDDuration400323000JPY
Interest income noiPrior1YTDDuration386000JPY
Interest income noiCurrentYTDDuration363000JPY
Dividends income noiPrior1YTDDuration2217000JPY
Dividends income noiCurrentYTDDuration2243000JPY
Foreign exchange gains noiPrior1YTDDuration9991000JPY
Foreign exchange gains noiCurrentYTDDuration10930000JPY
Insurance income noiPrior1YTDDuration－JPY
Insurance income noiCurrentYTDDuration11831000JPY
Subsidy income noiPrior1YTDDuration7667000JPY
Subsidy income noiCurrentYTDDuration－JPY
Other noiPrior1YTDDuration5470000JPY
Other noiCurrentYTDDuration4532000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass